Hospital Pharmacy - June 2018 - 186

186
Regarding reasons for not reporting ADR, the present
study reveals 53.9%, 51.9%, 41%, 21.7%, and 13.6% of
respondents fail to report ADR due to the unavailability of
reporting form, uncertainty of how to report, lack of feedback, lack of time, and forgetfulness, respectively. In a similar fashion, the study conducted in West Ethiopia at Nekemte
town showed that uncertainty of how to report and unavailability of reporting form are suggested to be discouraging
factors.24 In addition, our findings are closely related to the
study conducted in tertiary hospitals of North India.30

Conclusion
The results of our study at HFSUH stated poor awareness,
knowledge, and practice toward spontaneous ADR reporting
system. In addition, most of the participants are not clear
with the concerned body in the country who is responsible to
address ADR-related issues. Therefore, we recommended inservice training to promote its related problems along with
appropriate reporting system, which is at the heart of pharmacovigilance systems to enhance spontaneous and voluntary ADR reporting.
Acknowledgments
The authors are very grateful to Haramaya University for their unreserved support for the success of the study. We extend our sincere
gratitude to our data collectors and the study participants for their
kindness and willingness to involve in our study.

Author Contributions
HS involved in the development of the concept, preparation of proposal, and write-up. JA supervised throughout the study periods,
critically evaluated the findings, involved in write up and prepared
the final manuscript for publication. Both the authors read and
approved the final version of the manuscript thoroughly.

Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this article.

Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.

References
1. Sivadasan S, Yuong NY, Chyi NW, et al. Knowledge and perception towards pharmacovigilance and adverse drug reaction
reporting among medicine and pharmacy students. World J
Pharm Pharmaceut Sci. 2014;3(3):1652-1676.
2. Srikanth BA, Hailu W, Admassie E, Patel I, Khan TM.
Knowledge, attitude and practices of health professional towards
adverse drug reactions reporting in Gondar University Hospital
Northwest Ethiopia. Afr J Health Sci. 2014;27(1):46-56.
3. Edwards IR, Aronson JK. Adverse drug reactions: definitions,
diagnosis, and management. Lancet. 2000;356:1255-1259.

Hospital Pharmacy 53(3)
4. Oshikoya KA. Adverse drug reaction in children: types, incidence and risk factors. Niger J Paediatr. 2006;33:29-35.
5. Elkami RM, Hassali MA, Ibrahim MI, Liau SY, Awaisu A. A
qualitative study exploring barriers and facilitators for reporting of adverse drug reactions among community pharmacists in
Malaysia. J Pharm Health Serv Res. 2011;2:71-78.
6. Chetty S, Parida A, Adiga S, Bairy KL. Knowledge, attitude
and practice of health care professionals towards adverse drug
reaction reporting in a South Indian teaching hospital. World J
Pharm Res. 2014;3(3):4263-4271.
7. Dilbato DD, Kuma ZG, Teklemariam S. A baseline survey
on prescribing indicators and the underlying factors influencing prescribing in southern Ethiopia. Ethiop J Health Dev.
1998;12(2):87-93.
8. Waller PC. Making the most of spontaneous adverse drug reaction reporting. Basic Clin Pharmacol Toxicol. 2006;98:320323. doi:10.1111/j.1742-7843.2006.pto_286.x.
9. Vallano A, Cereza G, Pedròs C, et al. Obstacles and solutions
for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653-658.
10. Morrison-Griffiths S, Pirmohamed M. Specialist nurse
reporting of adverse drug reactions. Prof Nurse. 2000;15(5):
300-304.
11. Ulfvarson J, Mejyr S, Begman U. Nurses are increasingly
involved in pharmacovigilance in Sweden. Pharmacoepidemiol
Drug Saf. 2007;16(5):532-537. doi:10.1002/pds.1336.
12. Backstrom M, Mjorndal T, Dahlqvist R. Spontaneous reporting
of adverse drug reactions by nurses. Pharmacoepidemiol Drug
Saf. 2003;12(2):157-159. doi:10.1002/pds.753.
13. Drug Administration and Control Authority in collaboration
with MSH/RPM plus/SPS. Report on the assessment of health
care providers' knowledge, attitude and practice on adverse
drug reaction (ADR) reporting and its monitoring. Addis
Ababa, Ethiopia. http://www.fmhaca.gov.et/documents/ADR_
Study.pdf. Published 2008. Accessed October 4, 2017.
14. Wilke RA, Lin DW, Roden DM, et al. Identifying genetic risk
factors for serious adverse drug reactions: current progress and
challenges. Nat Rev Drug Discov. 2007;6(11):904-916.
15. World Health Organization. Pharmacovigilance: Ensuring the
Safe Use of Medicines. Geneva, Switzerland: World Health
Organization; 2004.
16. Iffat W, Shakeel S, Naseem S, Imam S, Khan M. Attitudinal survey to assess medical and dental students belief of ADR reporting in Pakistan. Int J Pharm Pharm Sci. 2014;6(5):279-283.
17. Bule MH, Hamido BA, Chala TS, Kefeni GT. Knowledge, attitudes and practices of healthcare professionals towards adverse
drug reaction reporting in Adama Hospital Medical College,
East Shoa zone, Oromia regional state, Ethiopia. Pharma
Innovation. 2016;5(7):24-28.
18. Tariku B, Mulisa M, Tesema S. Health professionals' knowledge, attitude and practices towards adverse drug reaction
reporting in Nekemte Hospital, Ethiopia. MD-Medical Data.
2015;7(1): 041-046.
19. Ganesan S, Vikneswaran G, Reddy KC, Subrahmanyam DK,
Adithan C. A survey on knowledge, attitude and practice of
pharmacovigilance towards adverse drug reactions reporting
among doctors and nurses in a tertiary care hospital in South
India. J Young Pharm. 2016;8(4):471-476.
20. Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, HernandezDiaz S, Lasheras B. Factors that influence under-reporting of

http://www.fmhaca.gov.et/documents/ADR_Study.pdf http://www.fmhaca.gov.et/documents/ADR_Study.pdf

Table of Contents for the Digital Edition of Hospital Pharmacy - June 2018